Literature DB >> 26777763

Effects of Diabetes on Salivary Gland Protein Expression of Tetrahydrobiopterin and Nitric Oxide Synthesis and Function.

Cassandra R Stewart1, Nneka Obi1, Elodie C Epane1, Alexander A Akbari1, Leslie Halpern2, Janet H Southerland2, Pandu R Gangula1,3,4.   

Abstract

BACKGROUND: Xerostomia is defined as dry mouth resulting from a change in the amount or composition of saliva and is often a major oral health complication associated with diabetes mellitus (DM). Studies have shown that xerostomia is more common in females at the onset of DM. Evidence suggests that nitric oxide (NO) plays a critical role in healthy salivary gland function. However, the specific mechanisms by which NO regulates salivary gland function at the onset of DM have yet to be determined. This study has two aims: 1) to determine whether protein expression or dimerization of NO synthase enzymes (neuronal [nNOS] and endothelial [eNOS]) are altered in the onset of diabetic xerostomia; and 2) to determine whether the changes in nNOS/eNOS protein expression or dimerization are correlated with changes in NO cofactor tetrahydrobiopterin (BH4) biosynthetic enzymes (guanosine triphosphate cyclohydrolase-1 and dihydrofolate reductase).
METHODS: Functional and Western blot studies were performed in streptozotocin-induced and control Sprague-Dawley female rats with DM (type 1 [t1DM]) using standardized protocols. Confirmation of xerostomia was determined by increased water intake and decreased salivary flow rate.
RESULTS: The results showed that in female rats with DM, salivary hypofunction is correlated with decreased submandibular and parotid gland sizes. The results also show a decrease in NOS and BH4 biosynthetic enzyme in submandibular glands.
CONCLUSIONS: These results indicate that a decrease in submandibular NO-BH4 protein expression may provide insight pertaining to mechanisms for the development of hyposalivation in DM-induced xerostomia. Furthermore, understanding the role of the NO-BH4 pathway may give insight into possible treatment options for the patient with DM experiencing xerostomia.

Entities:  

Keywords:  Biopterin; diabetes mellitus; nitric oxide; nitric oxide synthase; saliva; xerostomia

Mesh:

Substances:

Year:  2016        PMID: 26777763      PMCID: PMC4882217          DOI: 10.1902/jop.2016.150639

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  34 in total

1.  Distribution of nitric oxide synthase containing elements in the feline submandibular gland.

Authors:  Z Lohinai; A D Székely; L Soós; E Fehér
Journal:  Neurosci Lett       Date:  1995-06-02       Impact factor: 3.046

2.  Nitric oxide synthase in the autonomic and sensory ganglia innervating the submandibular salivary gland.

Authors:  S Soinila; S Vanhatalo; A Lumme; N Băck; J Soinila
Journal:  Microsc Res Tech       Date:  1996-09-01       Impact factor: 2.769

3.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

Authors:  E Stroes; J Kastelein; F Cosentino; W Erkelens; R Wever; H Koomans; T Lüscher; T Rabelink
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

4.  Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.

Authors:  A C Gorren; A Schrammel; K Schmidt; B Mayer
Journal:  Biochemistry       Date:  1997-04-08       Impact factor: 3.162

5.  Determination of nitric oxide synthase cofactors: heme, FAD, FMN, and tetrahydrobiopterin.

Authors:  P Klatt; K Schmidt; E R Werner; B Mayer
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

6.  Nitric oxide synthase immunoreactive nerves in rat and ferret salivary glands, and effects of denervation.

Authors:  P Alm; J Ekström; B Larsson; G Tobin; K E Andersson
Journal:  Histochem J       Date:  1997-09

7.  Development of tetrahydrobiopterin and GTP cyclohydrolase in salivary glands of rats.

Authors:  S Katoh; T Sueoka
Journal:  Int J Biochem       Date:  1986

8.  Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate.

Authors:  P Klatt; K Schmidt; G Uray; B Mayer
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

9.  Tetrahydrobiopterin-dependent stabilization of neuronal nitric oxide synthase dimer reduces susceptibility to phosphorylation by protein kinase C in vitro.

Authors:  D Okada
Journal:  FEBS Lett       Date:  1998-09-04       Impact factor: 4.124

10.  Xerostomia in diabetes mellitus.

Authors:  L M Sreebny; A Yu; A Green; A Valdini
Journal:  Diabetes Care       Date:  1992-07       Impact factor: 19.112

View more
  5 in total

1.  Salivary exosomes as a new therapy to ameliorate diabetes mellitus and combat xerostomia and submandibular salivary glands dysfunction in diabetic rats.

Authors:  Zeinab A Salem; Amany Hany Mohamed Kamel; Nermeen AbuBakr
Journal:  J Mol Histol       Date:  2021-01-03       Impact factor: 2.611

2.  Salivary Flow Alteration in Patients Undergoing Treatment for Schizophrenia: Disease-Drug-Target Gene/Protein Association Study for Side-effects.

Authors:  Anusa Arunachalam Mohandoss; Rooban Thavarajah
Journal:  J Oral Biol Craniofac Res       Date:  2019-06-15

3.  Sphingolipids metabolism in the salivary glands of rats with obesity and streptozotocin induced diabetes.

Authors:  Marta Garbowska; Bartłomiej Łukaszuk; Agnieszka Mikłosz; Igor Wróblewski; Krzysztof Kurek; Lucyna Ostrowska; Adrian Chabowski; Małgorzata Żendzian-Piotrowska; Anna Zalewska
Journal:  J Cell Physiol       Date:  2017-04-27       Impact factor: 6.384

4.  Human dental pulp stem cells attenuate streptozotocin-induced parotid gland injury in rats.

Authors:  Rasha H Al-Serwi; Ahmed Othman Fathy Othman El-Kersh; Gehan El-Akabawy
Journal:  Stem Cell Res Ther       Date:  2021-11-14       Impact factor: 6.832

Review 5.  Salivary gland proteins alterations in the diabetic milieu.

Authors:  Malak Fouani; Charbel A Basset; Abdo R Jurjus; Lavinia Giovanna Leone; Giovanni Tomasello; Angelo Leone
Journal:  J Mol Histol       Date:  2021-07-01       Impact factor: 2.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.